Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Kimio Takai"'
Publikováno v:
International Neurourology Journal, Vol 24, Iss 4, Pp 358-364 (2020)
Purpose The aim of this study was to determine the significance of the membranous urethral length (MUL), including the thickness of the urethral sphincter, for recovery from postoperative stress urinary incontinence (SUI) following holmium laser enuc
Externí odkaz:
https://doaj.org/article/2002c8a46fe7411f8f9c11b171bfd4e7
Publikováno v:
International Neurourology Journal
International Neurourology Journal, Vol 24, Iss 4, Pp 358-364 (2020)
International Neurourology Journal, Vol 24, Iss 4, Pp 358-364 (2020)
Purpose: The aim of this study was to determine the significance of the membranous urethral length (MUL), including the thickness of the urethral sphincter, for recovery from postoperative stress urinary incontinence (SUI) following holmium laser enu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154a30e1c164aa4efea653eb730cefe6
https://doi.org/10.5213/inj.2040042.021
https://doi.org/10.5213/inj.2040042.021
Autor:
Kazuhiro Nagao, Kazuo Oba, Seiji Kitahara, Akinobu Suga, Nakanori Fuji, Shiro Yamaguchi, Satoru Yoshihiro, Junji Yatsuda, Mototsugu Shimokawa, Jumpei Akao, Shigeru Sakano, Kimio Takai, Tomomi Kamba, Mitsutaka Yamamoto, Akihiko Aoki, Tomoyuki Shimabukuro, Yoshiaki Yamamoto, Yoriaki Kamiryo, Yasuhide Tei, Hiroaki Matsumoto, Hideyasu Matsuyama
Publikováno v:
International journal of clinical oncology. 26(1)
Pembrolizumab is effective in a limited number of patients with advanced urothelial carcinoma (UC). Therefore, we evaluated the prognostic value of clinical biomarkers following pembrolizumab treatment in patients with advanced UC. We retrospectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678b340a7c77a2b208c2cb6157740bd4
https://pubmed.ncbi.nlm.nih.gov/32948925
https://pubmed.ncbi.nlm.nih.gov/32948925
Autor:
Yasuhide Tei, Seiji Kitahara, Yoriaki Kamiryo, Tomoyuki Shimabukuro, Akihiko Aoki, Satoru Yoshihiro, Keiji Joko, Mitsutaka Yamamoto, Hideyasu Matsuyama, Kazuhiro Nagao, Baba Y, Kimio Takai, Akinobu Suga, Shigeru Sakano, Jumpei Akao, Takahito Nasu, Hiroaki Matsumoto, Shiro Yamaguchi
Publikováno v:
International Journal of Clinical Oncology
Background Currently, there is no consensus regarding which patients with high-risk prostate cancer (PCa) would benefit the most by radical prostatectomy (RP). We aimed to identify patients with high-risk PCa who are treatable by RP alone. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0eb6889b017beb5a50ccf7565387903
https://doi.org/10.1007/s10147-018-1272-9
https://doi.org/10.1007/s10147-018-1272-9
Autor:
Yoshiaki Yamamoto, Takeshi Hiragino, Nakanori Fuji, Mitsutaka Yamamoto, Hiroaki Matsumoto, Kazuhiro Nagao, Yoriaki Kamiryo, Kimio Takai, Kazuo Oba, Hideyasu Matsuyama, Akihiko Aoki, Shigeru Sakano
Publikováno v:
Japanese journal of clinical oncology. 50(2)
Background Nivolumab is a standard treatment for previously treated advanced renal-cell carcinoma. However, nivolumab is effective in only a limited number of patients; therefore, we evaluated the prognostic value of several biomarkers, including inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d434fbba304e6649ea9ae5ed5f26cb52
https://pubmed.ncbi.nlm.nih.gov/31755525
https://pubmed.ncbi.nlm.nih.gov/31755525
Autor:
Shintaro Oka, Kazuhiro Nagao, Mitsutaka Yamamoto, Seiji Kitahara, Takeshi Hiragino, Nakanori Fujii, Hirotaka Komatsu, Kimio Takai, Manabu Tsukamoto, Hideyasu Matsuyama, Satoru Yoshihiro, Kazuo Oba, Akinobu Suga, Yoshiaki Yamamoto, Taku Misumi, Jumpei Akao, Yoriaki Kamiryo, Akihiko Aoki, Shigeru Sakano, Hiroaki Matsumoto
Publikováno v:
Journal of Clinical Oncology. 38:724-724
724 Background: Nivolumab is a standard treatment for previously treated advanced renal-cell carcinoma (RCC). However, nivolumab is effective in only a limited number of patients; therefore, we evaluated the prognostic value of several biomarkers, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::887150b27b4e7e8c9f3127caeae028ee
https://doi.org/10.1200/jco.2020.38.6_suppl.724
https://doi.org/10.1200/jco.2020.38.6_suppl.724
Autor:
Kimio Takai, Satoru Yoshihiro, Akihiko Aoki, Norio Yamamoto, Mitsutaka Yamamoto, Baba Y, Yoriaki Kamiryo, Akinobu Suga, Shigeaki Hayashida, Yoshitaka Kaneda, Hideyasu Matsuyama, Tomoyuki Shimabukuro, Takahito Nasu, Kazuo Oba, Shigeru Sakano
Publikováno v:
International Journal of Clinical Oncology. 20:362-368
Patients with urinary bladder urothelial carcinoma (UC) with variant histology have features of more advanced disease and a likelihood of poorer survival than those with pure UC. We investigated the impact of variant histology on disease aggressivene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937779a6539bc9c528f5e30f0444f506
https://doi.org/10.1007/s10147-014-0721-3
https://doi.org/10.1007/s10147-014-0721-3
Autor:
Yoshitaka Kaneda, Akihiko Aoki, Keiji Joko, Satoru Yoshihiro, Kimio Takai, Baba Y, Satoshi Shirataki, Akinobu Suga, Osamu Hashimoto, Mitsutaka Yamamoto, Hideyasu Matsuyama, Shigeru Sakano, Shigeaki Hayashida, Yoriaki Kamiryo
Publikováno v:
BJU International. 107:1598-1604
Study Type – Therapy (case series) Level of Evidence 4 What’s known on the subject? and What does the study add? EAU guidelines on non-muscle-invasive bladder tumours have been widely used for the prediction of recurrence after TUR. However, ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cebff5aad64ae79f9947a90834934fa
https://doi.org/10.1111/j.1464-410x.2010.09850.x
https://doi.org/10.1111/j.1464-410x.2010.09850.x
Publikováno v:
Transplant Immunology. 23:174-179
FTY720 is known to not only accelerate lymphocyte homing to secondary lymphoid organs but also induce apoptosis in lymphocytes. To investigate the effect of FTY720 in rat thymocytes, rats were intramuscularly injected with 10 mg/kg/day of FTY720. Lig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0aacf7871eef0ebdfda3fc1994f2611
https://doi.org/10.1016/j.trim.2010.06.003
https://doi.org/10.1016/j.trim.2010.06.003
Autor:
Yoriaki Kamiryo, Hideyasu Matsuyama, Akinobu Suga, Sigeru Sakano, Norio Yamamoto, Baba Y, Yasuhide Tei, Mitsutaka Yamamoto, Akihiko Aoki, Katsuhiko Imoto, Satoru Yoshihiro, Keiji Joko, M Konishi, Kimio Takai, Shiro Yamaguchi, Shigeaki Hayashida, Takahiko Hara, Seiji Yano, Takahito Nasu
Publikováno v:
International journal of clinical oncology. 21(1)
The standard of care for treatment of localized muscle-invasive bladder cancer (MIBC) is radical cystectomy (RC). The patient's condition may affect management of MIBC, especially for elderly patients with more comorbid conditions and lower performan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55039af69f2d7cf79c364ddd44a35e92
https://pubmed.ncbi.nlm.nih.gov/27302779
https://pubmed.ncbi.nlm.nih.gov/27302779